No Data
No Data
Elutia | 10-Q: Quarterly report
Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024
SILVER SPRING, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia"), a company pioneering drug-eluting biomatrix products, is excited to announce its participation in the upco
Earnings Call Summary | Elutia(ELUT.US) Q1 2024 Earnings Conference
The following is a summary of the Elutia, Inc. (ELUT) Q1 2024 Earnings Call Transcript:Financial Performance:Elutia reported Q1 revenue of $6.7 million, which represented substantial growth.The compan
Elutia Is Maintained at Overweight by Cantor Fitzgerald
Elutia Is Maintained at Overweight by Cantor Fitzgerald
Elutia Price Target Cut to $5.00/Share From $6.00 by Cantor Fitzgerald
Elutia Price Target Cut to $5.00/Share From $6.00 by Cantor Fitzgerald
Express News | Cantor Fitzgerald Maintains Overweight on Elutia, Lowers Price Target to $5
No Data